Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor

Malay K. Raychowdhury, Masao Yukawa, Laura J. Collins, Sonja H. McGrail, K. Craig Kent, J. Anthony Ware

Research output: Contribution to journalArticle

291 Citations (Scopus)

Abstract

Thromboxane A2 (TxA2) causes contraction of vascular smooth muscle and aggregation of platelets; paradoxically, it also induces formation of the vasodilator and antiaggregant prostacyclin by human endothelium. To determine if the molecular structure of the endothelial TxA2 receptor differs from that of the previously characterized receptor from placenta, we isolated a putative TxA2 receptor cDNA from a human endothelial library. The predicted amino acid sequence revealed a structure of 369 amino acids, in which a novel cytoplasmic tail replaced the carboxyl-terminal portion of the previously characterized TxA2 receptor; this divergence in cytoplasmic domains resulted from the nonsplicing of a potential intron in the placenta TxA2 receptor. Northern hybridization reveals that the expression of the TxA2 receptor in endothelial RNA decreases 6-fold following stimulation with an endoperoxide analog. Polymerase chain reaction using oligonucleotide primers specific to each cytoplasmic domain revealed that only the novel receptor was expressed in endothelium, while both receptors were expressed in placenta. Overexpression of the endothelial TxA2 receptor cDNA in Chinese hamster ovary cells conferred the ability to bind a known receptor antagonist and mobilize Ca2+ in response to TxA2 mimetics. This finding of a new TxA2 receptor in endothelium suggests that a family of these receptors may result from alternative splicing of the cytoplasmic (carboxyl) tail.

Original languageEnglish (US)
Pages (from-to)19256-19261
Number of pages6
JournalJournal of Biological Chemistry
Volume269
Issue number30
StatePublished - Jul 29 1994

Fingerprint

Prostaglandin H2 Receptors Thromboxane A2
Alternative Splicing
Tail
Placenta
Endothelium
Thromboxane A2
Complementary DNA
Amino Acids
DNA Primers
Polymerase chain reaction
Epoprostenol
Platelets
Cricetulus
Molecular Structure
Vasodilator Agents
Platelet Aggregation
Vascular Smooth Muscle
Introns
Molecular structure
Libraries

ASJC Scopus subject areas

  • Biochemistry

Cite this

Raychowdhury, M. K., Yukawa, M., Collins, L. J., McGrail, S. H., Craig Kent, K., & Ware, J. A. (1994). Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. Journal of Biological Chemistry, 269(30), 19256-19261.

Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. / Raychowdhury, Malay K.; Yukawa, Masao; Collins, Laura J.; McGrail, Sonja H.; Craig Kent, K.; Ware, J. Anthony.

In: Journal of Biological Chemistry, Vol. 269, No. 30, 29.07.1994, p. 19256-19261.

Research output: Contribution to journalArticle

Raychowdhury, MK, Yukawa, M, Collins, LJ, McGrail, SH, Craig Kent, K & Ware, JA 1994, 'Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor', Journal of Biological Chemistry, vol. 269, no. 30, pp. 19256-19261.
Raychowdhury, Malay K. ; Yukawa, Masao ; Collins, Laura J. ; McGrail, Sonja H. ; Craig Kent, K. ; Ware, J. Anthony. / Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. In: Journal of Biological Chemistry. 1994 ; Vol. 269, No. 30. pp. 19256-19261.
@article{698d284e03e14f28a2d8a4f7cda5b212,
title = "Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor",
abstract = "Thromboxane A2 (TxA2) causes contraction of vascular smooth muscle and aggregation of platelets; paradoxically, it also induces formation of the vasodilator and antiaggregant prostacyclin by human endothelium. To determine if the molecular structure of the endothelial TxA2 receptor differs from that of the previously characterized receptor from placenta, we isolated a putative TxA2 receptor cDNA from a human endothelial library. The predicted amino acid sequence revealed a structure of 369 amino acids, in which a novel cytoplasmic tail replaced the carboxyl-terminal portion of the previously characterized TxA2 receptor; this divergence in cytoplasmic domains resulted from the nonsplicing of a potential intron in the placenta TxA2 receptor. Northern hybridization reveals that the expression of the TxA2 receptor in endothelial RNA decreases 6-fold following stimulation with an endoperoxide analog. Polymerase chain reaction using oligonucleotide primers specific to each cytoplasmic domain revealed that only the novel receptor was expressed in endothelium, while both receptors were expressed in placenta. Overexpression of the endothelial TxA2 receptor cDNA in Chinese hamster ovary cells conferred the ability to bind a known receptor antagonist and mobilize Ca2+ in response to TxA2 mimetics. This finding of a new TxA2 receptor in endothelium suggests that a family of these receptors may result from alternative splicing of the cytoplasmic (carboxyl) tail.",
author = "Raychowdhury, {Malay K.} and Masao Yukawa and Collins, {Laura J.} and McGrail, {Sonja H.} and {Craig Kent}, K. and Ware, {J. Anthony}",
year = "1994",
month = "7",
day = "29",
language = "English (US)",
volume = "269",
pages = "19256--19261",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "30",

}

TY - JOUR

T1 - Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor

AU - Raychowdhury, Malay K.

AU - Yukawa, Masao

AU - Collins, Laura J.

AU - McGrail, Sonja H.

AU - Craig Kent, K.

AU - Ware, J. Anthony

PY - 1994/7/29

Y1 - 1994/7/29

N2 - Thromboxane A2 (TxA2) causes contraction of vascular smooth muscle and aggregation of platelets; paradoxically, it also induces formation of the vasodilator and antiaggregant prostacyclin by human endothelium. To determine if the molecular structure of the endothelial TxA2 receptor differs from that of the previously characterized receptor from placenta, we isolated a putative TxA2 receptor cDNA from a human endothelial library. The predicted amino acid sequence revealed a structure of 369 amino acids, in which a novel cytoplasmic tail replaced the carboxyl-terminal portion of the previously characterized TxA2 receptor; this divergence in cytoplasmic domains resulted from the nonsplicing of a potential intron in the placenta TxA2 receptor. Northern hybridization reveals that the expression of the TxA2 receptor in endothelial RNA decreases 6-fold following stimulation with an endoperoxide analog. Polymerase chain reaction using oligonucleotide primers specific to each cytoplasmic domain revealed that only the novel receptor was expressed in endothelium, while both receptors were expressed in placenta. Overexpression of the endothelial TxA2 receptor cDNA in Chinese hamster ovary cells conferred the ability to bind a known receptor antagonist and mobilize Ca2+ in response to TxA2 mimetics. This finding of a new TxA2 receptor in endothelium suggests that a family of these receptors may result from alternative splicing of the cytoplasmic (carboxyl) tail.

AB - Thromboxane A2 (TxA2) causes contraction of vascular smooth muscle and aggregation of platelets; paradoxically, it also induces formation of the vasodilator and antiaggregant prostacyclin by human endothelium. To determine if the molecular structure of the endothelial TxA2 receptor differs from that of the previously characterized receptor from placenta, we isolated a putative TxA2 receptor cDNA from a human endothelial library. The predicted amino acid sequence revealed a structure of 369 amino acids, in which a novel cytoplasmic tail replaced the carboxyl-terminal portion of the previously characterized TxA2 receptor; this divergence in cytoplasmic domains resulted from the nonsplicing of a potential intron in the placenta TxA2 receptor. Northern hybridization reveals that the expression of the TxA2 receptor in endothelial RNA decreases 6-fold following stimulation with an endoperoxide analog. Polymerase chain reaction using oligonucleotide primers specific to each cytoplasmic domain revealed that only the novel receptor was expressed in endothelium, while both receptors were expressed in placenta. Overexpression of the endothelial TxA2 receptor cDNA in Chinese hamster ovary cells conferred the ability to bind a known receptor antagonist and mobilize Ca2+ in response to TxA2 mimetics. This finding of a new TxA2 receptor in endothelium suggests that a family of these receptors may result from alternative splicing of the cytoplasmic (carboxyl) tail.

UR - http://www.scopus.com/inward/record.url?scp=0027936171&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027936171&partnerID=8YFLogxK

M3 - Article

VL - 269

SP - 19256

EP - 19261

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 30

ER -